Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 11 studies | 31% ± 11% | |
oligodendrocyte precursor cell | 11 studies | 35% ± 14% | |
adipocyte | 11 studies | 78% ± 12% | |
fibroblast | 11 studies | 30% ± 9% | |
glutamatergic neuron | 8 studies | 35% ± 18% | |
pericyte | 8 studies | 30% ± 10% | |
smooth muscle cell | 7 studies | 30% ± 9% | |
astrocyte | 6 studies | 31% ± 17% | |
hepatocyte | 5 studies | 59% ± 32% | |
GABAergic neuron | 5 studies | 39% ± 14% | |
cardiac muscle cell | 5 studies | 31% ± 8% | |
mesothelial cell | 3 studies | 38% ± 15% | |
connective tissue cell | 3 studies | 21% ± 6% | |
interneuron | 3 studies | 42% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 94% | 1279.18 | 231 / 245 | 97% | 27.73 | 489 / 502 |
liver | 100% | 7602.15 | 226 / 226 | 88% | 20.15 | 359 / 406 |
breast | 99% | 6665.72 | 455 / 459 | 84% | 9.92 | 939 / 1118 |
kidney | 93% | 925.31 | 83 / 89 | 65% | 7.25 | 587 / 901 |
adrenal gland | 88% | 919.14 | 227 / 258 | 66% | 6.77 | 151 / 230 |
thymus | 94% | 1133.69 | 617 / 653 | 36% | 3.39 | 219 / 605 |
lung | 86% | 889.05 | 495 / 578 | 38% | 3.24 | 434 / 1155 |
skin | 88% | 1148.51 | 1596 / 1809 | 28% | 2.09 | 134 / 472 |
intestine | 87% | 1116.45 | 838 / 966 | 24% | 1.13 | 128 / 527 |
uterus | 79% | 699.59 | 135 / 170 | 31% | 2.12 | 140 / 459 |
bladder | 95% | 1101.10 | 20 / 21 | 13% | 0.67 | 66 / 504 |
ovary | 81% | 786.79 | 145 / 180 | 24% | 1.02 | 102 / 430 |
esophagus | 68% | 720.19 | 982 / 1445 | 36% | 2.81 | 66 / 183 |
stomach | 78% | 1079.29 | 279 / 359 | 26% | 1.57 | 74 / 286 |
adipose | 100% | 9660.48 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 5815.22 | 803 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 1342.73 | 1294 / 1335 | 0% | 0 | 0 / 0 |
heart | 79% | 882.54 | 682 / 861 | 0% | 0 | 0 / 0 |
spleen | 57% | 488.80 | 137 / 241 | 0% | 0 | 0 / 0 |
pancreas | 11% | 67.73 | 35 / 328 | 46% | 2.59 | 82 / 178 |
brain | 3% | 23.30 | 70 / 2642 | 51% | 2.18 | 357 / 705 |
tonsil | 0% | 0 | 0 / 0 | 40% | 2.41 | 18 / 45 |
eye | 0% | 0 | 0 / 0 | 3% | 0.09 | 2 / 80 |
peripheral blood | 0% | 2.77 | 4 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0006897 | Biological process | endocytosis |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0048009 | Biological process | insulin-like growth factor receptor signaling pathway |
GO_0060396 | Biological process | growth hormone receptor signaling pathway |
GO_0032870 | Biological process | cellular response to hormone stimulus |
GO_0032107 | Biological process | regulation of response to nutrient levels |
GO_0070555 | Biological process | response to interleukin-1 |
GO_0040014 | Biological process | regulation of multicellular organism growth |
GO_0043406 | Biological process | positive regulation of MAP kinase activity |
GO_0019530 | Biological process | taurine metabolic process |
GO_0045597 | Biological process | positive regulation of cell differentiation |
GO_0051384 | Biological process | response to glucocorticoid |
GO_0050731 | Biological process | positive regulation of peptidyl-tyrosine phosphorylation |
GO_0040018 | Biological process | positive regulation of multicellular organism growth |
GO_0009629 | Biological process | response to gravity |
GO_0009755 | Biological process | hormone-mediated signaling pathway |
GO_0032094 | Biological process | response to food |
GO_0042445 | Biological process | hormone metabolic process |
GO_0046427 | Biological process | positive regulation of receptor signaling pathway via JAK-STAT |
GO_0060351 | Biological process | cartilage development involved in endochondral bone morphogenesis |
GO_0007259 | Biological process | cell surface receptor signaling pathway via JAK-STAT |
GO_0005615 | Cellular component | extracellular space |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0043235 | Cellular component | receptor complex |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0036464 | Cellular component | cytoplasmic ribonucleoprotein granule |
GO_0043025 | Cellular component | neuronal cell body |
GO_0070195 | Cellular component | growth hormone receptor complex |
GO_0009986 | Cellular component | cell surface |
GO_0005829 | Cellular component | cytosol |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0008289 | Molecular function | lipid binding |
GO_0019903 | Molecular function | protein phosphatase binding |
GO_0070064 | Molecular function | proline-rich region binding |
GO_0019955 | Molecular function | cytokine binding |
GO_0017046 | Molecular function | peptide hormone binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0042169 | Molecular function | SH2 domain binding |
GO_0004903 | Molecular function | growth hormone receptor activity |
GO_0019838 | Molecular function | growth factor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | GHR |
Protein name | GHR protein Growth hormone receptor (Somatotropin receptor) Growth hormone receptor (GH receptor) (Somatotropin receptor) [Cleaved into: Growth hormone-binding protein (GH-binding protein) (GHBP) (Serum-binding protein)] Growth hormone receptor Mutant growth hormone receptor Truncated growth hormone receptor |
Synonyms | |
Description | FUNCTION: Receptor for pituitary gland growth hormone involved in regulating postnatal body growth. On ligand binding, couples to the JAK2/STAT5 pathway (By similarity). .; FUNCTION: The soluble form (GHBP) acts as a reservoir of growth hormone in plasma and may be a modulator/inhibitor of GH signaling.; FUNCTION: Isoform 2 up-regulates the production of GHBP and acts as a negative inhibitor of GH signaling. FUNCTION: The soluble form (GHBP) acts as a reservoir of growth hormone in plasma and may be a modulator/inhibitor of GH signaling. . |
Accessions | E7ES05 E9PCN7 ENST00000537449.5 [P10912-1] ENST00000513671.5 ENST00000615111.4 [P10912-1] ENST00000612626.4 [P10912-1] A0A8A6U7T3 A0A087X162 A0A8A6UB81 A0A087X0H5 P10912 ENST00000618088.4 [P10912-1] ENST00000357703.6 [P10912-4] Q9NRZ8 ENST00000620156.4 A0A8A6UC02 ENST00000612382.4 [P10912-1] ENST00000511135.5 B9EGJ3 ENST00000230882.9 [P10912-1] ENST00000622294.2 Q9HCW9 |